IMI

Intermolecular, Inc.
IMI

Delisted

IMI was delisted on the 19th of September, 2019.

Back to rankings

32 hedge funds and large institutions have $20.9M invested in Intermolecular, Inc. in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

308% more capital inflows, than outflows

Capital inflows: $1.55M | Capital outflows: $380K

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

14% more funds holding

Funds holding: 28 → 32 (+4)

2.34% more ownership

Funds ownership: 39.2% → 41.54% (+2.3%)

33% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 9

Holders
32
Holders Change
+4
Holders Change %
+14.29%
% of All Funds
0.71%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
6
Reduced
9
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EM
Emancipation Management
New York
+$410K
2
DC
Diametric Capital
Massachusetts
+$343K
3
JP Morgan Chase
JP Morgan Chase
New York
+$329K
4
PCM
Prelude Capital Management
New York
+$157K
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$157K

Top Sellers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
-$168K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$150K
3
JFA
JNBA Financial Advisors
Minnesota
-$19K
4
HK
Horizon Kinetics
New York
-$10.8K
5
ISL
Ingalls & Snyder LLC
New York
-$10K

IMI Hedge Fund Activity: Q4 2018 in Review

32 of the 4,506 institutional investors tracked by Wall St. Rank reported a position in Intermolecular, Inc. (IMI) for Q4 2018, worth a combined $20.9M — down 8.5% from $22.8M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new IMI positions and 3 closed out — a net gain of 4 holders — while 6 added to existing stakes and 9 trimmed.

The largest buyer was Emancipation Management, adding an estimated $410K. The largest seller was Bridgeway Capital Management, cutting an estimated $168K.

  • 32 institutional investors held Intermolecular, Inc. (IMI) as of Q4 2018, up from 28 in Q3 2018.
  • Funds reported $20.9M of Intermolecular, Inc. stock for Q4 2018, down 8.5% quarter-over-quarter.
  • 7 funds opened new Intermolecular, Inc. positions in Q4 2018 and 3 closed out, a net change of +4 holders.
  • The largest Intermolecular, Inc. buyer in Q4 2018 was Emancipation Management, an estimated $410K added.
  • The largest Intermolecular, Inc. seller in Q4 2018 was Bridgeway Capital Management, an estimated $168K sold.

Based on aggregated 13F filings for Q4 2018.